Advertisement

Topics

Possible Mislabeling of Tablets as Capsules Leads to Voluntary Recall

08:00 EDT 31 Jul 2017 | PharmPro

Apace Packaging LLC is voluntarily recalling one lot of Cyclobenzaprine HCl tablets and one lot of Amantadine HCl capsules due to potential mislabeling.
Contributed Author: 
FDA MedWatch
Topics: 

Original Article: Possible Mislabeling of Tablets as Capsules Leads to Voluntary Recall

NEXT ARTICLE

More From BioPortfolio on "Possible Mislabeling of Tablets as Capsules Leads to Voluntary Recall"

Quick Search
Advertisement